DiaMedica Therapeutics (DMAC) Interest & Investment Income (2019 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Interest & Investment Income of -$76000.0 for Q1 2026, down 322.22% year-over-year from $34200.0 in Q1 2025, and up 93.5% quarter-over-quarter from -$1.2 million in Q4 2025.
DiaMedica Therapeutics (DMAC) Interest & Investment Income (2019 - 2026) Analysis & Trends
DiaMedica Therapeutics' Interest & Investment Income history runs 8 years deep, the most recent figure standing at -$76000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 322.22% year-over-year to -$76000.0; the TTM figure through Mar 2026 stood at -$825000.0 (down 135.44% YoY), while the FY2025 annual figure was $27000.0, down 98.83% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$76000.0, up from -$1.2 million in the prior quarter.
- The five-year high for Interest & Investment Income was $2.2 million in Q4 2024, with the low at -$1.2 million in Q4 2025.
- The 5-year median for Interest & Investment Income is -$18000.0 (2025), against an average of $199176.5.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income sank 6100.0% in 2022, then soared 2177.27% in 2023.
- DiaMedica Therapeutics' Interest & Investment Income stood at $88000.0 in 2022, then jumped by 2177.27% to $2.0 million in 2023, then climbed by 11.08% to $2.2 million in 2024, then slumped by 152.56% to -$1.2 million in 2025, then surged by 93.5% to -$76000.0 in 2026.
- Business Quant data shows DMAC's Interest & Investment Income at -$76000.0 in Q1 2026, -$1.2 million in Q4 2025, and $440000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - | -11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11,000.00 |
| Mar 31, 2026 | -76,000.00 |
| Dec 31, 2025 | -1.17 Mn |
| Sep 30, 2025 | 440,000.00 |
| Jun 30, 2025 | -19,000.00 |
| Mar 31, 2025 | -18,000.00 |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | -12,000.00 |
| Mar 31, 2024 | -45,000.00 |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | -64,000.00 |
| Jun 30, 2023 | -34,000.00 |
| Mar 31, 2023 | 45,000.00 |
| Dec 31, 2022 | 88,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | -60,000.00 |
| Mar 31, 2022 | -56,000.00 |
| Dec 31, 2021 | -46,000.00 |
| Sep 30, 2021 | -2,000.00 |